Is Ceryvyn Therapeutics Limited (CKDXF) a Buy, Sell, or Hold?
OTC : CKDXF
Ceryvyn Therapeutics Limited
$0.01 USD
$0 (0.0%)
- Volume
- 130
- Average Volume
- 819
- Market Capitalization
- $13.68M
- P/E Ratio
- 0.06
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.44
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.52
3333332"{?
p/.m7yd f,0=
Annual earnings financials
CKDXF financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
CKDXF Estimated and Actual Revenue by Quarter
CKDXF Estimated and Actual EPS by Quarter
CKDXF Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2025-06-30 | 1 | -100000 | -100000 | -100000 | -100000 | -100000 | -100000 |
| 2024-06-30 | 1 | -100000 | -100000 | -100000 | -100000 | -100000 | -100000 |
CKDXF Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2025-06-30 | 1 | -11.99M | -11.99M | -11.99M | 34.4M | 34.4M | 34.4M |
| 2024-06-30 | 1 | -193.32M | -193.32M | -193.32M | 34.4M | 34.4M | 34.4M |
CKDXF Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2025-06-30 | 1 | 100000 | 100000 | 100000 | 1 | -0.009 | -0.009 | -0.009 |
| 2024-06-30 | 1 | 100000 | 100000 | 100000 | 1 | -0.157 | -0.157 | -0.157 |